SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001576885-24-000055
Filing Date
2024-04-22
Accepted
2024-04-22 16:30:32
Documents
6
Period of Report
2024-06-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a.htm DEF 14A 546017
2 GRAPHIC acumenproxycardinbw001.jpg GRAPHIC 194991
3 GRAPHIC acumenproxycardinbw002.jpg GRAPHIC 99712
4 GRAPHIC image_0.jpg GRAPHIC 27597
5 GRAPHIC picture1.jpg GRAPHIC 7937
6 GRAPHIC picture2.jpg GRAPHIC 3176
  Complete submission text file 0001576885-24-000055.txt   1003887
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40551 | Film No.: 24861551
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)